The Pharma Data

JUNE 2, 2022

Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR.

Antibody 52

Antibody Licensing Licensing Development 52

pharmaphorum

JANUARY 6, 2021

Several others are in late-stage development, including fitusiran for haemophilia, which Sanofi is developing under license from Alnylam. In 2019 the Danish company also licensed a preclinical-stage, small-molecule candidate for NASH from Japan’s UBE.

Gene Silencing 66

Gene Silencing Gene RNA Contract Manufacturing 66

Roots Analysis

FEBRUARY 27, 2024

Currently, product licensing agreements, technology licensing agreements, research and development agreements and clinical trial agreements are the common types of partnerships inked by developers that are currently focused on the development of ADCs pipeline.

Antibody 52

Antibody Licensing Licensing Contract Manufacturing 52

Outsourcing Pharma

FEBRUARY 28, 2023

The company agrees to license a laboratory and office space to accelerate its drug discovery and diagnostic capabilities.

Licensing 52

Licensing Licensing Drugs Contract Manufacturing 52

Roots Analysis

FEBRUARY 15, 2022

However, several ADC developers do not have the in-house capabilities to manufacture cytotoxic payload on a commercial scale and tend to rely on contract manufacturers. As per the estimates, 70-80% of ADC manufacturing operations are outsourced. Increased Partnership Activity.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Marketing Containment 52

Camargo

FEBRUARY 4, 2021

The notice specified the two facility types: An OTC monograph drug facility is a foreign or domestic entity engaged in manufacturing or processing the finished dosage form of an OTC monograph drug. The Agency refers to such facility as a Monograph Drug Facility (MDF). The fee listed for MDFs was $14,060. Emphasis added).

Development 131

Development Production Drugs Manufacturing 131

pharmaphorum

NOVEMBER 12, 2020

Handl’s technology portfolio stems from licensing deals with Prof Linden’s former employer King’s College London, as well as Belgium’s KU Leuven, the Centre for Applied Medical Research in Spain, and the University of Chile.

Gene Therapy 52

Gene Therapy Gene Manufacturing Contract Manufacturing 52

The Pharma Data

MARCH 16, 2021

In partnering with the Lieber Institute, Boehringer Ingelheim has in-licensed preclinical pipeline candidates, representing a first-in-class approach for targets in neuropsychiatric disorders. The potential of centrally acting COMT inhibitors has not yet been evaluated in the clinic due to the unavailability of such compounds.

Development 52

Development Contract Manufacturing Licensing Licensing 52

The Pharma Data

MARCH 2, 2021

Boehringer Ingelheim and Gubra today announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the treatment of obesity. In 2019, Boehringer Ingelheim achieved net sales of 19 billion euros. Our significant investment of almost 3.5

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52

The Pharma Data

NOVEMBER 17, 2021

Pfizer has begun and will continue to invest up to roughly$ 1 billion of its own finances to support the manufacturing and distribution of this investigational treatment seeker. It has entered into advance purchase agreements with several countries and has initiated bilateral outreach to roughly 100 countries around the world.

HR 52

HR Manufacturing Contract Manufacturing Licensing 52

The Pharma Data

NOVEMBER 19, 2021

Pfizer has also begun and will continue to invest up to roughly$ 1 billion of its own finances to support the manufacturing and distribution of this investigational treatment seeker, including exploring implicit contract manufacturing options.

HR 52

HR Contract Manufacturing Manufacturing Clinical Trials 52

The Pharma Data

MARCH 22, 2022

Pfizer continues to invest to support the manufacturing and distribution of PAXLOVID, including exploring potential contract manufacturing options. High and upper-middle income countries will pay more than lower income countries.

In-Vitro 52

In-Vitro Contract Manufacturing Manufacturing Development 52

The Pharma Data

JANUARY 27, 2021

The following risks and uncertainties may cause our actual results, levels of activity, performance, or achievements to differ materially from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements: our ability to raise capital to fund our operations, including but not limited to, (..)

Clinical Trials 52

Clinical Trials Clinical Trials Production Trials 52

Pfizer

DECEMBER 13, 2021

All the while, they've continued partnering with contract manufacturing organizations (CMOs) to further increase production as they work toward their goal of 3 billion doses in 2021. Adding flexibility and increasing volume has been key. Understanding mRNA COVID-19 Vaccines. Centers for Disease Control and Prevention.

Manufacturing 52

Manufacturing Vaccination Vaccine Production 52

The Pharma Data

DECEMBER 23, 2020

INOVIO is also assessing nonclinical efficacy of INO-4800 in several animal challenge models with Public Health England (PHE) and Commonwealth Scientific and Industrial Research Organization (CSIRO) in Australia.

DNA 40

DNA Vaccination Vaccine Immune Response 40

The Pharma Data

NOVEMBER 15, 2020

The following risks and uncertainties may cause our actual results, levels of activity, performance, or achievements to differ materially from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements: our ability to raise capital to fund our operations, including but not limited to, (..)

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

pharmaphorum

JANUARY 7, 2021

The biotech would likely struggle to supply without the help of its new big pharma partner, although it has been expanding its production capacity in the last few weeks with the help of contract manufacturers like Wacker and Fareva.

Vaccination 105

Vaccination Vaccine Contract Manufacturing Development 105

The Pharma Data

DECEMBER 15, 2020

Under the agreement, Aurena Laboratories will establish a production unit to meet the regulatory requirements for the manufacture of Lipidor’s pharmaceutical products. This is an important step towards a licensing agreement for Lipidor drug candidates, AKP01 and AKP02, for the treatment of psoriasis.

Contract Manufacturing 52

Contract Manufacturing Manufacturing Production Drugs 52

Roots Analysis

FEBRUARY 26, 2024

In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017. Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs Contract Manufacturing 52

The Pharma Data

JULY 21, 2021

The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. We believe this collaboration will create opportunity to more broadly distribute vaccine doses to people in harder-to-reach communities, especially those on the African continent.”.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

JANUARY 5, 2021

based contract manufacturing business, Benuvia Manufacturing, which has significant chemistry and formulation capabilities, including manufacturing our FDA-approved cannabinoid drug, SYNDROS ® ,” said Todd C. We look forward to supporting Radius through our U.S.

Manufacturing 52

Manufacturing FDA Approval Trials Development 52

The Pharma Data

NOVEMBER 2, 2020

We will also use data provided by our Korean R&D and contract manufacturing partner as part of their extensive product development schedule and as part of the XPRIZE initiative. The same data that will be produced by the company’s Pennsylvania testing partner will be used for submissions to the EU and Russian Federation.

Manufacturing 40

Manufacturing Contract Manufacturing Production Engineer 40

The Pharma Data

NOVEMBER 5, 2020

The FDA accepted for priority review, with a target action date of February 28, 2021 , the supplemental Biologics License Application (sBLA) for Libtayo ® (cemiplimab) as monotherapy to treat patients with first-line locally advanced or metastatic non-small cell lung cancer (NSCLC) with ?50% Cost of collaboration and contract manufacturing.

Sales 40

Sales Production Manufacturing Antibody 40

The Pharma Data

MAY 4, 2021

billion, primarily driven by Pfizer CentreOne, Pfizer’s contract manufacturing operation, reflecting sales of legacy Upjohn products to Viatris (4) and remdesivir to Gilead Sciences Inc., 7) BNT162b2 has not been approved or licensed by the U.S. Hospital products, which grew 10% operationally to $2.3

Vaccine 40

Vaccine Vaccination Production Sales 40

The Pharma Data

JUNE 24, 2021

The production capacity has consistently grown due to continued enhancements to the vaccine’s supply chain, which include expanding existing facilities, adding more suppliers, and bringing on additional Pfizer/BioNTech sites and contract manufacturers around the world to produce the vaccine.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

pharmaphorum

JUNE 2, 2021

Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by round 300 million doses a year, following an agreement to set up a new production line at contract manufacturer Lonza. Full approval means it could be used routinely in future as an annual booster, much like the seasonal influenza vaccine.

Vaccine 52

Vaccine Vaccination Contract Manufacturing Production 52